Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV Study of Benvitimod Cream for Mild to Moderate Psoriasis in Adults
ChiCTR2100051898Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tapinarof in psoriasis, sponsored by Peking University People's Hospital. Primary endpoints: Psoriasis Area and Severity Index (PASI) score and Investigator's global assessment (PGA) percentage decline. Started Jun 2021; status: recruiting.
02
Drugs
tapinarof
03
Conditions
psoriasis
Beyond the preview
Go deeper on ChiCTR2100051898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051898.